Difference between revisions of "Team:British Columbia/Part Collection"

Line 48: Line 48:
 
<p>Did your team make a lot of great parts? Is there a theme that ties all your parts together? Do you have more than 10 parts in this collection? Did you make a CRISPR collection, a MoClo collection, or a collection of awesome pigment parts? Describe your parts collection on this page, so the judges can evaluate you for the Best Part Collection award.</p>
 
<p>Did your team make a lot of great parts? Is there a theme that ties all your parts together? Do you have more than 10 parts in this collection? Did you make a CRISPR collection, a MoClo collection, or a collection of awesome pigment parts? Describe your parts collection on this page, so the judges can evaluate you for the Best Part Collection award.</p>
  
 +
 +
-->
  
 
</div>
 
</div>
−
</div>
+
</div></html>
−
</div>
+
−
-->
+
−
</html>
+
  
 
{{:Team:British Columbia/Template/Fixedfooter}}
 
{{:Team:British Columbia/Template/Fixedfooter}}

Revision as of 01:07, 19 September 2015

UBC iGEM 2015

 

Part Collection

 

Our collection of parts contains genes required for modification of imidacloprid and degradation of 6-chloronicotinic acid (6-CNA). Final parts were assembled in pSB1C3 backbone harboring the chloramphenicol resistance gene and designed to have a LacI repressor, ribosome binding site, pTAC promoter, our degradation genes of interest, and double terminator.

The three composite parts each containing a cytochrome P450 (CYP) were designed to include an N-terminal pelB signal sequence to target expression to the periplasm and a cytochrome P450 reductase (CPR) for functionality of the CYP. The CPR was also made with it’s own designated rbs, promoter, pelB signal sequence, and terminator.

Composite parts with multiple degradation genes were designed so that each gene in the construct had a dedicated rbs, promoter, and double terminator.

Header 1Header 2Header 3
Row:1 Cell:1Row:1 Cell:2Row:1 Cell:3

Created with the HTML Table Generator